The CEO of the company said this to shareholders in august:
Our Androgenetic Alopecia-201 topical trial is an ongoing Phase 2 open-label clinical trial of ATI-502 for the topical treatment of androgenetic alopecia or Androgenetic Alopecia, also known as male or female pattern hair loss. This ongoing trial will evaluate the...